IMUX · XBRL financial data

Immunic financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (IMUX's year ends in late December)

In thousands of dollarsSep 30, 2023†Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Research and development19,79619,284*18,73618,32321,37021,617*21,53321,36920,01219,069*25,62625,931
General and administrative3,7744,097*5,1454,4914,3564,014*5,2925,7145,9814,258*7,6099,396
Total operating expenses23,57023,381*23,88122,81425,72625,631*26,82527,08325,99323,327*33,23535,327
Operating income (loss)(23,570)(23,381)*(23,881)(22,814)(25,726)(25,631)*(26,825)(27,083)(25,993)(23,327)*(33,235)(35,327)
Interest income766541*1,187998776429*183241419197*7601,286
Other income (expense)351,268*(2,094)43658227*1,16922(5)3,830*(113)(58)
Income tax expense (benefit)—————————year only——
Net income (loss)(22,769)(21,572)*(29,584)(21,380)(24,368)(25,175)*(25,473)(26,820)(25,579)(19,300)*(32,588)(34,099)
Earnings per share, basic USD per share(0.51)(0.48)*(0.30)(0.21)(0.24)(0.25)*(0.25)(0.20)(0.13)—(1.08)(0.80)
Earnings per share, diluted USD per share(0.51)(0.48)*(0.30)(0.21)(0.24)(0.25)*(0.25)(0.20)(0.13)—(1.08)(0.80)
Weighted average shares, basic thousands of shares44,57444,595*97,300101,273101,273100,835*101,344132,175193,898193,898*30,13642,514
Weighted average shares, diluted thousands of shares44,57444,595*97,300101,273101,273100,835*101,344132,175193,898193,898*30,13642,514
  • † Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (IMUX's year ends in late December)

In thousands of dollarsSep 30, 2023†Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents59,68946,67497,31279,69859,07135,66814,30455,31035,13215,483186,629155,098
Prepaid and other current assets5,5455,8605,3035,2804,1953,6644,6714,5324,1417,3862,1302,735
Total current assets65,23452,534102,61584,97863,26639,33218,97559,84239,27322,869188,759157,833
Property and equipment, net288466442585618545572612640608566771
Right-of-use asset1,4121,2991,098928878991968975791575417565
Total assets66,97754,299104,15586,49164,76240,86820,51561,42940,70424,052189,742159,169
Accounts payable3,1995,0996,7677,8946,0427,8466,0117,8937,91810,13811,01112,665
Accrued liabilities13,65918,66412,41913,77516,24512,91318,28918,11319,45418,64522,43217,852
Total current liabilities17,78124,72920,14622,67723,35722,17525,59227,31330,07930,61838,36331,260
Lease liability, non-current789639433241186264210205126107146328
Total liabilities18,57025,36820,57922,91823,54322,43925,80227,51830,20530,72538,50931,588
Accumulated deficit(389,320)(410,892)(440,476)(461,856)(486,224)(511,399)(536,872)(563,692)(589,271)(608,571)(641,159)(675,258)
Total stockholders' equity48,40728,93183,57663,57341,21918,429(5,287)33,91110,499(6,673)151,233127,581
Total liabilities and equity66,97754,299104,15586,49164,76240,86820,51561,42940,70424,052189,742159,169
Common shares outstanding (cover page) thousands of shares45,14589,92990,07990,07990,07990,15195,81898,651120,285130,46513,62213,644
  • † Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (IMUX's year ends in late December)

In thousands of dollarsSep 30, 2023†Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(22,769)(21,572)*(29,584)(21,380)(24,368)(25,175)*(25,473)(26,820)(25,579)(19,300)*(32,588)(34,099)
Stock-based compensation1,687*1,638*2,7501,882*1,910*1,985*2,0421,899*3,614*1,308*4,4666,782*
Depreciation and amortization34*23*2631*42*35*4343*40*42*3334*
Net cash from operating activities(17,312)*(14,027)*(23,969)(17,031)*(20,803)*(22,963)*(21,776)(24,609)*(20,140)*(19,281)*(17,301)(30,998)*
Purchases of property and equipment44*165*31180*50*3*4736*67*11*2249*
Net cash from investing activities(44)*(165)*(31)(180)*(50)*(3)*(47)(36)*(67)*(11)*(2)(249)*
Proceeds from issuing common stock282*571*1910*0*0*00*0*0*——
Net cash from financing activities282*604*74,4640*0*77*065,518*0*59*188,642118*
Net change in cash(17,605)*(13,015)*50,638(17,614)*(20,627)*(23,403)*(21,364)41,006*(20,178)*(19,649)*171,146(31,531)*
  • † Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.